Literature DB >> 9200388

Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction.

Y Sakata1, K Kodama, K Komamura, Y J Lim, F Ishikura, A Hirayama, M Kitakaze, T Masuyama, M Hori.   

Abstract

Salutary effect of nicorandil, a K+ adenosine triphosphate channel opener, on restoration of myocardial blood flow and functional improvement after coronary revascularization was investigated in 20 patients with first anterior acute myocardial infarction. Ten patients received intracoronary administration of nicorandil (2 mg) after coronary revascularization; the other 10 patients received coronary revascularization only and served as control subjects. Myocardial contrast echocardiography and two-dimensional echocardiography were performed to assess microvascular integrity and regional function in the infarcted area. Nicorandil improved peak contrast intensity ratio (p < 0.001), calculated as the ratio of peak contrast intensity in the infarcted and noninfarcted areas, indicating the restoration of myocardial blood flow to the infarcted myocardium. Regional wall motion improved more significantly in 1 month in patients who received nicorandil (p < 0.01). Thus our results suggested the usefulness of intracoronary nicorandil administration after coronary revascularization for restoring blood flow and functional improvement in patients with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200388     DOI: 10.1016/s0002-8703(97)70162-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

Review 1.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

2.  Potential of microvascular reperfusion with adjunctive pharmacological intervention: its impact on myocardial perfusion and functional outcomes in patients with acute myocardial infarction.

Authors:  Y Taniyama; H Ito; R Morishita; T Ogihara
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Complications of coronary intervention: device embolisation, no-reflow, air embolism.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2013-04-30

Review 4.  Reperfusion revisited: beyond TIMI 3 flow.

Authors:  J P Gassler; E J Topol
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

Review 5.  Treatment strategies for microvascular dysfunction following acute myocardial infarction.

Authors:  M T Roe
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

6.  Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits.

Authors:  Xian-Liang Tang; Yu-Ting Xuan; Yanqing Zhu; Gregg Shirk; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-18       Impact factor: 4.733

7.  The relationship of intracoronary stent placement following thrombolytic therapy to tissue level perfusion.

Authors:  C Michael Gibson; Daniel Frisch; Sabina A Murphy; Steven G Gourlay; Raymond Gibbons; Kenneth W Baran; Michel Nguyen; Sebastian Palmeri; Hal V Barron
Journal:  J Thromb Thrombolysis       Date:  2002-04       Impact factor: 2.300

8.  Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction.

Authors:  N Ikeda; T Yasu; N Kubo; S Hashimoto; Y Tsuruya; M Fujii; M Kawakami; M Saito
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 9.  Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction.

Authors:  Antonio Rodríguez-Sinovas; Yaser Abdallah; Hans Michael Piper; David Garcia-Dorado
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

10.  Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow.

Authors:  Seishi Nakamura; Kazuya Takehana; Tetsuro Sugiura; Kengo Hatada; Shinichi Hamada; Junko Asada; Reisuke Yuyama; Jun Mimura; Yusuke Imuro; Hirohiko Kurihara; Masayoshi Fukui; Masato Baden; Toshiji Iwasaka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.